$1.1 Billion is the total value of Rubric Capital Management LP's 56 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 90.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Buy | SPDR S&P 500 ETF TRput | $188,423,000 | +211.7% | 750,000 | +200.0% | 17.06% | +37.0% |
QQQ | New | POWERSHARES QQQ TRUSTput | $145,450,000 | – | 1,000,000 | +100.0% | 13.17% | – |
IWM | New | ISHARES TRput | $111,135,000 | – | 750,000 | +100.0% | 10.06% | – |
TSG | New | STARS GROUP INC | $35,325,000 | – | 1,728,700 | +100.0% | 3.20% | – |
CIEN | New | CIENA CORP | $33,373,000 | – | 1,519,025 | +100.0% | 3.02% | – |
HRTX | Buy | HERON THERAPEUTICS INC | $30,685,000 | +30.3% | 1,900,000 | +11.8% | 2.78% | -42.7% |
CNDT | Buy | CONDUENT INC | $28,751,000 | +52.9% | 1,834,801 | +55.5% | 2.60% | -32.8% |
MX | Buy | MAGNACHIP SEMICONDUCTOR CORP | $25,543,000 | +35.4% | 2,250,500 | +16.9% | 2.31% | -40.5% |
AABA | Buy | ALTABA INC | $24,708,000 | +86.6% | 373,000 | +53.5% | 2.24% | -18.0% |
KRA | Buy | KRATON CORPORATION | $24,586,000 | +615.1% | 607,952 | +509.1% | 2.23% | +214.1% |
NKTR | New | NEKTAR THERAPEUTICS | $23,924,000 | – | 996,835 | +100.0% | 2.17% | – |
GMS | Buy | GMS INC | $23,895,000 | +87.5% | 675,000 | +48.9% | 2.16% | -17.6% |
EAGL | New | DOUBLE EAGLE ACQUISITION COR | $23,644,000 | – | 2,340,997 | +100.0% | 2.14% | – |
MU | Buy | MICRON TECHNOLOGY INC | $23,598,000 | +203.9% | 600,000 | +130.8% | 2.14% | +33.6% |
RYAM | Buy | RAYONIER ADVANCED MATLS INC | $23,494,000 | +136.1% | 1,714,864 | +170.9% | 2.13% | +3.8% |
IGT | New | INTERNATIONAL GAME TECHNOLOG | $19,883,000 | – | 809,904 | +100.0% | 1.80% | – |
NSM | Buy | NATIONSTAR MTG HLDGS INC | $17,154,000 | +19.2% | 923,774 | +14.8% | 1.55% | -47.6% |
PTEN | New | PATTERSON UTI ENERGY INC | $16,605,000 | – | 793,000 | +100.0% | 1.50% | – |
MITL | Buy | MITEL NETWORKS CORP | $16,547,000 | +58.6% | 1,972,352 | +39.0% | 1.50% | -30.3% |
XPER | Buy | XPERI CORP | $15,528,000 | +22.6% | 613,769 | +44.4% | 1.41% | -46.1% |
CJ | New | C&J ENERGY SVCS INC NEW | $15,191,000 | – | 506,857 | +100.0% | 1.38% | – |
SC | New | SANTANDER CONSUMER USA HDG I | $13,953,000 | – | 907,839 | +100.0% | 1.26% | – |
HALO | Buy | HALOZYME THERAPEUTICS INC | $13,601,000 | +253.6% | 783,000 | +161.0% | 1.23% | +55.4% |
AMKR | Buy | AMKOR TECHNOLOGY INC | $12,541,000 | +62.5% | 1,188,718 | +50.5% | 1.14% | -28.6% |
APTI | Buy | APPTIO INCcl a | $12,350,000 | +19.2% | 668,628 | +11.9% | 1.12% | -47.7% |
CSTM | Buy | CONSTELLIUM NVcl a | $11,635,000 | +52.7% | 1,135,116 | +2.8% | 1.05% | -32.9% |
REGI | Buy | RENEWABLE ENERGY GROUP INC | $10,839,000 | +474.7% | 892,068 | +512.6% | 0.98% | +152.4% |
PRTY | Buy | PARTY CITY HOLDCO INC | $10,598,000 | +73.1% | 782,135 | +100.0% | 0.96% | -23.9% |
BLDR | Buy | BUILDERS FIRSTSOURCE INC | $10,600,000 | +134.1% | 589,230 | +99.4% | 0.96% | +2.9% |
DFIN | Buy | DONNELLEY FINL SOLUTIONS INC | $10,563,000 | +206.7% | 489,943 | +226.6% | 0.96% | +34.8% |
BAK | Buy | BRASKEM S Asp adr pfd a | $10,288,000 | +67.7% | 384,725 | +29.9% | 0.93% | -26.3% |
EVHC | New | ENVISION HEALTHCARE CORP | $8,990,000 | – | 200,000 | +100.0% | 0.81% | – |
GRA | New | GRACE W R & CO DEL NEWcall | $7,215,000 | – | 100,000 | +100.0% | 0.65% | – |
TTMI | New | TTM TECHNOLOGIES INC | $6,532,000 | – | 425,000 | +100.0% | 0.59% | – |
CARS | New | CARS COM INC | $5,341,000 | – | 200,700 | +100.0% | 0.48% | – |
BG | New | BUNGE LIMITED | $5,210,000 | – | 75,000 | +100.0% | 0.47% | – |
MACK | New | MERRIMACK PHARMACEUTICALS IN | $4,913,000 | – | 337,868 | +100.0% | 0.44% | – |
BBX | New | BBX CAP CORP NEWcl a | $4,848,000 | – | 657,845 | +100.0% | 0.44% | – |
BMCH | Buy | BMC STK HLDGS INC | $4,017,000 | +69.0% | 188,143 | +72.9% | 0.36% | -25.7% |
New | NABRIVA THERAPEUTICS PLC | $2,457,000 | – | 300,000 | +100.0% | 0.22% | – | |
BW | New | BABCOCK & WILCOX ENTERPRIS I | $2,081,000 | – | 625,000 | +100.0% | 0.19% | – |
EAGLW | New | DOUBLE EAGLE ACQUISITION COR*w exp 09/16/202 | $207,000 | – | 300,000 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MAGNACHIP SEMICONDUCTOR CORP | 28 | Q3 2023 | 4.7% |
BGC PARTNERS INC | 20 | Q2 2023 | 4.6% |
MR COOPER GROUP INC | 20 | Q3 2023 | 5.9% |
PAR PACIFIC HOLDINGS INC | 18 | Q3 2023 | 3.9% |
RADIUS HEALTH INC | 16 | Q2 2022 | 4.3% |
CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 2.6% |
HERON THERAPEUTICS INC | 15 | Q3 2023 | 9.0% |
COLLEGIUM PHARMACEUTICAL INC | 15 | Q3 2023 | 3.9% |
AAR CORP | 14 | Q3 2023 | 3.2% |
GREEN PLAINS INC | 14 | Q3 2022 | 4.1% |
View Rubric Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
HERON THERAPEUTICS, INC. /DE/ | July 25, 2023 | 26,713,503 | 19.0% |
Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
View Rubric Capital Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
DFAN14A | 2024-05-08 |
DFAN14A | 2024-05-03 |
DFAN14A | 2024-05-01 |
DFAN14A | 2024-04-30 |
DFAN14A | 2024-04-29 |
DEFC14A | 2024-04-17 |
DFAN14A | 2024-04-17 |
SC 13D/A | 2024-04-16 |
PRRN14A | 2024-04-02 |
PRRN14A | 2024-03-26 |
View Rubric Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.